Sanara Medtech Inc
NASDAQ:SMTI

Watchlist Manager
Sanara Medtech Inc Logo
Sanara Medtech Inc
NASDAQ:SMTI
Watchlist
Price: 21.76 USD 0.32% Market Closed
Market Cap: 194.5m USD

Sanara Medtech Inc
Accrued Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Sanara Medtech Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Sanara Medtech Inc
NASDAQ:SMTI
Accrued Liabilities
$13.9m
CAGR 3-Years
19%
CAGR 5-Years
40%
CAGR 10-Years
39%
Haemonetics Corp
NYSE:HAE
Accrued Liabilities
$48.3m
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
1%
ICU Medical Inc
NASDAQ:ICUI
Accrued Liabilities
$285.2m
CAGR 3-Years
10%
CAGR 5-Years
25%
CAGR 10-Years
29%
Align Technology Inc
NASDAQ:ALGN
Accrued Liabilities
$506.8m
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
18%
Lantheus Holdings Inc
NASDAQ:LNTH
Accrued Liabilities
$228.8m
CAGR 3-Years
8%
CAGR 5-Years
42%
CAGR 10-Years
28%
Merit Medical Systems Inc
NASDAQ:MMSI
Accrued Liabilities
$158m
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
15%
No Stocks Found

Sanara Medtech Inc
Glance View

Market Cap
194.3m USD
Industry
Health Care

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 63 full-time employees. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. The surgical wound care products are used in specialties including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, oncology, plastic/reconstructive, podiatric, urology and vascular. The chronic wound care products are used across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities, and wound care centers.

SMTI Intrinsic Value
37.73 USD
Undervaluation 42%
Intrinsic Value
Price

See Also

What is Sanara Medtech Inc's Accrued Liabilities?
Accrued Liabilities
13.9m USD

Based on the financial report for Sep 30, 2025, Sanara Medtech Inc's Accrued Liabilities amounts to 13.9m USD.

What is Sanara Medtech Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
39%

Over the last year, the Accrued Liabilities growth was 26%. The average annual Accrued Liabilities growth rates for Sanara Medtech Inc have been 19% over the past three years , 40% over the past five years , and 39% over the past ten years .

Back to Top